Resultado de búsqueda
21 de nov. de 2022 · Bayley Scales of Infant and Toddler Development is the most frequently used tests in infant developmental assessment. The Bayley Scales helps in detecting developmental delay early and also in initiating early developmental intervention.
- Palanikumar Balasundaram, Indirapriya Darshini Avulakunta
- 2022/11/21
- 2020
1 de ene. de 2010 · The Bayley Infant Neurodevelopmental Screener (BINS) is a developmental screening instrument applicable for ages 3–24 months. The BINS was developed contemporaneously with the Bayley Scales of Infant Development—Second Edition (BSID-II), and incorporated some similar items and test materials.
- Glen P. Aylward
- 2010
The Bayley Infant Neurodevelopmental Screener (BINS): different test and different purpose. En: Weiss LG, Oakland T, Aylward G, eds. Bayley III Clinical Use and Interpretation. USA: Academic Press; 2010. pp. 201-233.
1 de dic. de 2020 · The Bayley Infant Neurodevelopmental Screener (BINS) is a standard screener of infant development that was developed, normed, and validated with the United States samples. 2 The BINS is used globally and with infants who are exposed to a significant risk of developmental delays. 3–5 Although the BINS is used regularly in ...
1 de ene. de 2001 · The Bayley Infant Neurodevelopmental Screener (BINS) is a recently developed instrument designed specifically for a high-risk infant population based on an earlier screening instrument, the ENORS (Aylward, 1995; Aylward, Verhulst, & Bell, 1988).
- Carol H. Leonard, Robert E. Piecuch, Bruce A. Cooper
- 2001
1 de ene. de 2010 · The Bayley Infant Neurodevelopmental Screener (BINS) is a developmental screening instrument applicable for ages 3–24 months. The BINS was developed contemporaneously with the Bayley Scales of Infant Development—Second Edition (BSID-II), and incorporated some similar items and test materials.
Application of Neurodevelopmental Screening to a Sample of South American Infants: The Bayley Infant Neurodevelopmental Screener (BINS) Ann Marie McCarthy, PhD, RN, FAAN, George L. Wehby, PhD, Sheila Barron, PhD, Glen P. Aylward, PhD, ABPP, Eduardo E. Castilla, MD, PhD, Lorette C. Javois, PhD, Norman Goco, MHS, and Jeffrey C. Murray, MD.
